Publication | Closed Access
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma
31
Citations
25
References
2020
Year
Anti-pd-1 ImmunotherapyCancer ImmunosurveillanceHepatocellular CarcinomaMedicineImmunologyImmune Checkpoint InhibitorLiver CancerImmunotherapyOncologyRadiation OncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1